يعرض 1 - 20 نتائج من 12,183 نتيجة بحث عن '"ACINAR"', وقت الاستعلام: 0.54s تنقيح النتائج
  1. 1
    Academic Journal

    المؤلفون: Zhou, Cancan1,2 (AUTHOR), Feng, Zhengyuan1,2 (AUTHOR), Qian, Weikun1,2 (AUTHOR), Zhu, Zeen1,2 (AUTHOR), Cao, Ruiqi1,2 (AUTHOR), Wang, Qiqi1,2 (AUTHOR), Zhang, Wunai3 (AUTHOR), Liu, Rujuan1,2 (AUTHOR), Wu, Shuai1,2 (AUTHOR), Hao, Jie1,2 (AUTHOR), Wang, Zheng1,2 (AUTHOR), Ma, Qingyong1,2 (AUTHOR), Wu, Zheng1,2 (AUTHOR) woozheng@xjtu.edu.cn, Li, Xuqi4 (AUTHOR) lixuqi@163.com

    المصدر: Biology Direct. 1/14/2025, Vol. 20 Issue 1, p1-14. 14p.

  2. 2
    Academic Journal

    المؤلفون: Eslinger, Cody1 (AUTHOR), Seddighzadeh, Bobak1 (AUTHOR), Yee, Claire2 (AUTHOR), Elsabbagh, Zaid1 (AUTHOR), Pai, Rish3 (AUTHOR), Hartley, Chris4 (AUTHOR), Starr, Jason5 (AUTHOR), Bekaii-Saab, Tanios1 (AUTHOR), Halfdanarson, Thorvardur R.6 (AUTHOR), Sonbol, Mohamad Bassam1 (AUTHOR) Sonbol.mohamad@mayo.edu

    المصدر: JCO Precision Oncology. 2025, Vol. 9, p1-10. 10p.

  3. 3
    Academic Journal

    المؤلفون: Tang, Hao-Yu1,2,3 (AUTHOR), Cao, Yi-Zhi3 (AUTHOR), Zhou, Yi-Wei3 (AUTHOR), Ma, Yu-Shui4 (AUTHOR), Jiang, Hong5 (AUTHOR), Zhang, Hui2 (AUTHOR), Jiang, Lin6 (AUTHOR), Yang, Qin-Xin1 (AUTHOR), Tang, Xiao-Mei3 (AUTHOR), Yang, Chun7 (AUTHOR), Liu, Xin-Yun1 (AUTHOR), Liu, Fu-Xing1 (AUTHOR), Liu, Ji-Bin1,2 (AUTHOR) tians2008@ntu.edu.cn, Fu, Da1,2,3 (AUTHOR) fuda@shsmu.edu.cn, Wang, Yun-Feng1,8 (AUTHOR) wangyunfeng197911@163.com, Yu, Hong1,9 (AUTHOR) yuhong@njmu.edu.cn

    المصدر: Journal of Advanced Research. Jan2025, Vol. 67, p253-267. 15p.

  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المؤلفون: Gerstein, Hertzel C.1 (AUTHOR) gerstein@mcmaster.ca, Yang, Mu1 (AUTHOR), Lee, Shun Fu1 (AUTHOR), Branch, Kelley R. H.2 (AUTHOR), Del Prato, Stefano3 (AUTHOR), Lam, Carolyn S. P.4 (AUTHOR), Lopes, Renato D.5 (AUTHOR), Pratley, Richard6 (AUTHOR), Rosenstock, Julio7 (AUTHOR), Sattar, Naveed8 (AUTHOR)

    المصدر: Diabetes, Obesity & Metabolism. Dec2024, Vol. 26 Issue 12, p6080-6084. 5p.

  6. 6
    Academic Journal

    المؤلفون: Li, Alina L.1 (AUTHOR), Sugiura, Kensuke1 (AUTHOR), Nishiwaki, Noriyuki1 (AUTHOR), Suzuki, Kensuke1,2 (AUTHOR), Sadeghian, Dorsay3,4 (AUTHOR), Zhao, Jun3,4 (AUTHOR), Maitra, Anirban3,4 (AUTHOR), Falvo, David5 (AUTHOR), Chandwani, Rohit1,5 (AUTHOR), Pitarresi, Jason R.1,6 (AUTHOR), Sims, Peter A.1,7 (AUTHOR), Rustgi, Anil K.1 (AUTHOR) akr2164@cumc.columbia.edu

    المصدر: Developmental Cell. Nov2024, Vol. 59 Issue 22, p3025-30304. 27280p.

  7. 7
    Academic Journal

    المؤلفون: Fu, Fei1,2 (AUTHOR) fufei9940@wchscu.cn, Li, Wanmeng2 (AUTHOR) 2023224070047@stu.scu.edu.cn, Zheng, Xiaoyin2 (AUTHOR) 2022224070024@stu.scu.edu.cn, Wu, Yaling2 (AUTHOR), Du, Dan1,2 (AUTHOR) dudan@wchscu.cn, Han, Chenxia1 (AUTHOR) dudan@wchscu.cn

    المصدر: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11474. 25p.

  8. 8
    Academic Journal

    المؤلفون: Frost, Fabian1 (AUTHOR), Weiss, Stefan1,2 (AUTHOR), Hertel, Johannes3 (AUTHOR), Rühlemann, Malte4 (AUTHOR), Bang, Corinna4 (AUTHOR), Franke, Andre4 (AUTHOR), Nauck, Matthias5 (AUTHOR), Dörr, Marcus6 (AUTHOR), Völzke, Henry7 (AUTHOR), Roggenbuck, Dirk8,9 (AUTHOR), Schierack, Peter8,9 (AUTHOR), Völker, Uwe2 (AUTHOR), Homuth, Georg2 (AUTHOR), Aghdassi, Ali A.1 (AUTHOR), Sendler, Matthias1 (AUTHOR), Lerch, Markus M.1 (AUTHOR), Weiss, Frank U.1 (AUTHOR) ulrich.weiss@med.uni-greifswald.de

    المصدر: Gut Pathogens. 10/19/2024, Vol. 16 Issue 1, p1-11. 11p.

  9. 9
    Academic Journal

    المؤلفون: Peng, Qi1,2 (AUTHOR), Li, Bin1,2 (AUTHOR), Song, Pengli1,2 (AUTHOR), Wang, Ruiyan1,2 (AUTHOR), Jiang, Jing1,2 (AUTHOR), Jin, Xuerui1,2 (AUTHOR), Shen, Jie1,2 (AUTHOR), Bao, Jingpiao1,2 (AUTHOR), Ni, Jianbo1,2 (AUTHOR) jianbo.ni@shgh.cn, Han, Xiao1,2 (AUTHOR) hanxiao714@126.com, Hu, Guoyong1,2 (AUTHOR) huguoyongsh@sina.com

    المصدر: British Journal of Pharmacology. Oct2024, Vol. 181 Issue 20, p4067-4084. 18p.

  10. 10
    Academic Journal

    المؤلفون: GAO He1, XU Xiaofan1, DUAN Lifang1, ZHANG Hong1,2 zhangh1227@163.com

    المصدر: Chinese Journal of Immunology. Oct2024, Vol. 40 Issue 10, p2229-2235. 7p.

  11. 11
    Academic Journal

    Alternate Title: A chloride channel in mouse pancreatic acinar cells is activated by sodium taurocholate and dependent on extracellular calcium but not reactive oxygen species pathway.

    المؤلفون: 阳小雅1, 林嘉伟2, 叶东3, 赵婵4, 王立伟5, 陈丽新5 tchenlixin@jnu.edu.cn

    المصدر: Chinese Journal of Pathophysiology. Oct2024, Vol. 40 Issue 10, p1806-1814. 9p.

  12. 12
    Academic Journal

    المؤلفون: Nagata, Rihito1 (AUTHOR), Takemura, Nobuyuki1 (AUTHOR) ntake@saitama-med.ac.jp, Ninomiya, Riki1 (AUTHOR), Yamada, Naganori1 (AUTHOR), Matsudaira, Shinichi1 (AUTHOR), Kimura, Akifumi1 (AUTHOR), Takayanagi, Natsuko2 (AUTHOR), Imada, Hiroki2 (AUTHOR), Maki, Akira1 (AUTHOR), Beck, Yoshifumi1 (AUTHOR)

    المصدر: Asian Journal of Endoscopic Surgery. Oct2024, Vol. 17 Issue 4, p1-5. 5p.

  13. 13
    Academic Journal

    المؤلفون: Wanqiong Zheng1 zwq5171717@163.com, Ye Tian2, Yiming Zhang1, Binnan Li1

    المصدر: Signa Vitae. Sep2024, Vol. 20 Issue 9, p56-62. 7p.

    مصطلحات موضوعية: *PANCREATIC acinar cells, *FLAVONOIDS, *CELL survival, *PANCREATITIS, *APOPTOSIS

  14. 14
    Academic Journal

    المؤلفون: Umashankar, Bala1,2,3 (AUTHOR), Eliasson, Lena4 (AUTHOR), Ooi, Chee Y.2,3,5 (AUTHOR), Kim, Ki Wook3,6 (AUTHOR), Shaw, James A.M.7 (AUTHOR), Waters, Shafagh A.1,2,3 (AUTHOR) shafagh.waters@unsw.edu.au

    المصدر: Journal of Cystic Fibrosis. Sep2024, Vol. 23 Issue 5, p842-852. 11p.

  15. 15
    Academic Journal

    المؤلفون: Hayashi, Hiroshi1,2 (AUTHOR) hiroshi.273@gmail.com, Morikawa, Yoshihiko2 (AUTHOR), Akahoshi, Shogo2 (AUTHOR), Ikegawa, Kento2 (AUTHOR), Matsui, Motohiro1 (AUTHOR), Makimoto, Atsushi1,2 (AUTHOR), Yuza, Yuki1 (AUTHOR)

    المصدر: Leukemia & Lymphoma. Sep2024, Vol. 65 Issue 9, p1366-1369. 4p.

  16. 16
    Academic Journal

    Alternate Title: Effect of RND3 on injury of AR42J cell in rats induced by caerulein.

    المؤلفون: 张瑜1 thesmough61@21cn.com, 高华1

    المصدر: Chinese Journal of Immunology. Sep2024, Vol. 40 Issue 9, p1822-1832. 6p.

  17. 17
    Academic Journal

    المؤلفون: Ortiz, Jose A.1,2 (AUTHOR), Ghazalli, Nadiah1,2 (AUTHOR), Lopez, Kassandra2 (AUTHOR), Rawson, Jeffrey1 (AUTHOR), McCown, Erika M.3 (AUTHOR), Oh, Eunjin3 (AUTHOR), Irimia, Jose M.3,4 (AUTHOR), Jou, Kevin1 (AUTHOR), Mares, Jacob1 (AUTHOR), Chen, Min-Hsuan5 (AUTHOR), Wu, Xiwei4 (AUTHOR), Zook, Heather N.1,2 (AUTHOR), Quijano, Janine C.1 (AUTHOR), Erdem, Neslihan1,2 (AUTHOR), Lizarraga, Anahy6 (AUTHOR), Kandeel, Fouad1 (AUTHOR), Fueger, Patrick T.2,3,4 (AUTHOR), Thurmond, Debbie C.2,3 (AUTHOR), Ku, Hsun Teresa1,2 (AUTHOR) hku@coh.org

    المصدر: Diabetes. Sep2024, Vol. 73 Issue 9, p1447-1461. 15p.

  18. 18
    Report

    المصدر: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

  19. 19
    Report

    المصدر: Phase II Study of Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

  20. 20
    Report

    المصدر: DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
    Adams S, Othus M, Patel SP, Miller KD, Chugh R, Schuetze SM, Chamberlin MD, Haley BJ, Storniolo AMV, Reddy MP, Anderson SA, Zimmerman CT, O'Dea AP, Mirshahidi HR, Ahnert JR, Brescia FJ, Hahn O, Raymond JM, Biggs DD, Connolly RM, Sharon E, Korde LA, Gray RJ, Mayerson E, Plets M, Blanke CD, Chae YK, Kurzrock R. A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clin Cancer Res. 2022 Jan 15;28(2):271-278. doi: 10.1158/1078-0432.CCR-21-2182. Epub 2021 Oct 29.
    Wagner MJ, Othus M, Patel SP, Ryan C, Sangal A, Powers B, Budd GT, Victor AI, Hsueh CT, Chugh R, Nair S, Leu KM, Agulnik M, Sharon E, Mayerson E, Plets M, Blanke C, Streicher H, Chae YK, Kurzrock R. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). J Immunother Cancer. 2021 Aug;9(8):e002990. doi: 10.1136/jitc-2021-002990.
    Patel SP, Mayerson E, Chae YK, Strosberg J, Wang J, Konda B, Hayward J, McLeod CM, Chen HX, Sharon E, Othus M, Ryan CW, Plets M, Blanke CD, Kurzrock R. A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort. Cancer. 2021 Sep 1;127(17):3194-3201. doi: 10.1002/cncr.33591. Epub 2021 Apr 21.
    Dai C, Liang S, Sun B, Kang J. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas. Front Endocrinol (Lausanne). 2020 Dec 11;11:608422. doi: 10.3389/fendo.2020.608422. eCollection 2020.
    Patel SP, Othus M, Chae YK, Giles FJ, Hansel DE, Singh PP, Fontaine A, Shah MH, Kasi A, Baghdadi TA, Matrana M, Gatalica Z, Korn WM, Hayward J, McLeod C, Chen HX, Sharon E, Mayerson E, Ryan CW, Plets M, Blanke CD, Kurzrock R. A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors. Clin Cancer Res. 2020 May 15;26(10):2290-2296. doi: 10.1158/1078-0432.CCR-19-3356. Epub 2020 Jan 22.